期刊文献+

冠状动脉搭桥术患者不同组织中几种血管活性肽的含量 被引量:9

Level of Peptides Endothelin?Angiotensin Ⅱ,Calcitonin Gene Related Peptide and Atrial Natriuretic Polypeptide in Different Tissues of Coronary Artery Bypass Graft Patients
下载PDF
导出
摘要 为探讨血液中重要多肽因子内皮素、血管紧张素Ⅱ及降钙素基因相关肽与心房钠尿肽在冠状动脉搭桥术患者不同组织中的含量及其意义。选择施行冠状动脉搭桥术患者 32例 ,术中取得病理心包、心耳组织及心包液以及静脉血。组织匀浆后取离心上清液 ;静脉血经抗凝、离心、取血浆 ,用放射免疫分析法测定冠状动脉搭桥术患者血浆及心包、心包液、心耳中的内皮素、血管紧张素Ⅱ、降钙素基因相关肽及心房钠尿肽含量。结果发现 ,血浆与心包液中的内皮素 1、血管紧张素Ⅱ及降钙素基因相关肽含量存在明显的差异 ,心包与心耳中的内皮素 1、血管紧张素Ⅱ及降钙素基因相关肽含量也存在明显差异。血浆与心包液中的心房钠尿肽无明显差别 ,而心包与心耳中的心房钠尿肽则存在明显的差异。结果提示 ,冠状动脉搭桥术患者血浆内皮素、降钙素基因相关肽、血管紧张素Ⅱ及心房钠尿肽均会出现明显的变化。 Aim To investigate the changes of endothelin (ET),calcitonin gene related peptide (CGRP), angiotensin Ⅱ (AngⅡ) and atrial natriuretic polypeptide (ANP) in plasma of patients underwent coronary artery bypass graft (CABG). Methords ET, CGRP, Ang Ⅱ and ANP in plasma of 32 patients with coronary heart disease who had the CABG operation were studied. The pericardium, auricle, pericardial fluid were got during the CABG operation. The tissue were homogenated, centrifuged and the supernatant was got; anticoagulant blood were centrifuged and the plasma was got then the ET, AngII, CGRP and ANP in the luquid were assayed by RIA. Results ET in the pericardial and auricle were very different (P<0.001). AngⅡ in the plasma and pericardial fluid were obviously different, and the same as that in the pericardium and auricle (P<0.001). CGRP in the plasma and pericardial fluid, pericardium and auricle, were also different (P<0.05,P<0.001). Though there was no difference of ANF between plasma and pericardial fluid, ANF in the pericardium was higher than in the auricle (P<0.001). Conclusion Different tissue of CABG patients had alternated ET,CGRP,AngⅡ and ANP.
出处 《中国动脉硬化杂志》 CAS CSCD 2003年第3期260-262,共3页 Chinese Journal of Arteriosclerosis
关键词 冠状动脉搭桥术 生物活性因子 放射免疫分析法 内皮素 降钙素基因相关肽 血管紧张素Ⅱ 心房钠尿肽 Endothelin Calcitonin Gene Related Peptide Angiotensin Ⅱ Atrial Natriuretic Polypeptide Coronary Artery Bypass Graft Coronary Heart Disease
  • 相关文献

同被引文献100

  • 1王佐广,温绍君,陈光慧,张维君,文杰,吴兆苏,罗毅,汤健.高血压相关基因HSG上游调控序列单核苷酸多态性的发现及其与高血压的关联[J].首都医科大学学报,2004,25(4):464-468. 被引量:3
  • 2唐新华,金宏义,蒋爱敏,周欢琴,许月珍.心血管危险因素对动脉弹性的影响[J].中华心血管病杂志,2005,33(5):476-477. 被引量:8
  • 3黄彦生,王树人,智艳芳,许波实,孙琳,吴彧,卢建敏,戴付敏.氧化型谷胱甘肽和辅酶Ⅱ与颈动脉粥样硬化的关系研究[J].中华心血管病杂志,2006,34(6):515-518. 被引量:11
  • 4Guideline Subcommittee. 1999 world health organization - internal society of hypertension guidelines for the management of hypertension [ J ]. J Hypertens, 1999,17 ( 2 ) : 151-183.
  • 5Bauyiedel G; Windsteetter U, Ddmao SJ. Migratory activity of human smooth muscle cells cultured from coronary and peripheral primary and restenotic lesions removed by percutaneous atherectomy [ J ]. Circulation, 1992,85 ( 2 ) :554-564.
  • 6Horichi M, Akishita M, Dzau VJ. Recent progress in angiotensin Ⅱ type 2 receptor research in the cardiovascular system[ J]. Hypertension, 1999,33 (2) :613-621.
  • 7Bernard I. Levy. Can Angiotensin Ⅱ Type 2 receptors have deleterious effects in cardiovascular disease? : implications for therapeutic blockade of the renin-angiotensin system[ J]. Circulation ,2004,109 (1) :8-13.
  • 8Chen KH, Guo X, Ma D, et al. Dysregulation of HSG triggers vascular proliferative disorders[ J]. Nat Cell Biol,2004,6(9 ) :872-883.
  • 9Tsutsui H, Matsushima S, Kinugawa S, et al. Angiotensin Ⅱ type 1 receptor blocker attenuates myocardial remodeling and preserves diastolic function in diabetic heart[J]. Hypertens Res,2007,30 (5) : 439-449.
  • 10Weber H, Taylor D, Molloy JL. Angiotensin induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells [ J ]. J Clin Invest, 1994,93 (2) :788-798.

引证文献9

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部